Reimbursement Intelligence Webinar:
Recorded: June 19, 2013, Noon ET
Download Webinar: Free
Who are the ad hoc physician advisors to formulary decision making?
How can we understand the role and participation of these advisors in determining product placement on formularies?
How will our brand be supported or evaluated by these key stakeholders?
What messaging is required to grow and protect our brand from current and future competitors?
From Real Endpoints:
Roger Longman| Managed Healthcare Executive| May 10, 2013
One of the biggest changes in healthcare right now is the transformation from a fee-for-service economy, and it will likely take longer than we expect. Still, payers and providers—and the various big and small service providers hoping to serve them—are already trying to improve business processes as diverse as connectivity, transparency and consumer communication.
Real Endpoints Symposium Highlights:
March 11-12, 2013
Brought to you by Ernst & Young and Real Endpoints
Highlights from the Symposium…
“The Evidence Challenge of Rational Reimbursement” Presented by Roger Longman, CEO, Real Endpoints.
Complimentary recording and slides available.
The Real Endpoints Blog
March 27 2013
How can oncology drug developers design their trials to satisfy both regulators and payers, and...